Cite
Recombinant and Chimeric Disintegrins in Preclinical Research.
MLA
David, Victor, et al. “Recombinant and Chimeric Disintegrins in Preclinical Research.” Toxins, vol. 10, no. 8, Aug. 2018, p. 321. EBSCOhost, https://doi.org/10.3390/toxins10080321.
APA
David, V., Succar, B. B., de Moraes, J. A., Saldanha-Gama, R. F. G., Barja-Fidalgo, C., & Zingali, R. B. (2018). Recombinant and Chimeric Disintegrins in Preclinical Research. Toxins, 10(8), 321. https://doi.org/10.3390/toxins10080321
Chicago
David, Victor, Barbara Barbosa Succar, João Alfredo de Moraes, Roberta Ferreira Gomes Saldanha-Gama, Christina Barja-Fidalgo, and Russolina Benedeta Zingali. 2018. “Recombinant and Chimeric Disintegrins in Preclinical Research.” Toxins 10 (8): 321. doi:10.3390/toxins10080321.